Herbal Antibiotics: Natural Alternatives for Treating Drug-Resistant Bacteria (70 page)

Head, Kathleen A. Natural approaches to prevention and treatment of infections of the lower urinary tract.
Altern Med Rev
13, no. 3 (2008): 227–44.

Hua, W., et al. Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry.
J Pharm Biomed Anal
44, no. 4 (2007): 931–37.

Hwang, B. Y., et al. Antimicrobial constituents from goldenseal (the rhizomes of
Hydrastis canadensis
) against selected oral pathogens.
Planta Med
69, no. 7 (2003): 623–27.

Imanshahidi, M., et al. Pharmacological and therapeutic effects of
Berberis vulgaris
and its active constituent, berberine.
Phytother Res
22, no. 8 (2008): 999–1012.

Inbaraj, J. J., et al. Photochemistry and photocytoxicity of alkaloids from goldenseal (
Hydrastis canadensis
L.). 2. Palmatine, hydrastine, canadine, and hydrastinine.
Chem Res Toxicol
19, no. 6 (2006): 739–44.

Jahnke, G. D., et al. Developmental toxicity evaluation of berberine in rats and mice.
Birth Defects Res B Dev Reprod Toxicol
77, no. 3 (2006): 195–206.

James, M. A., et al. Dietary administration of berberine or
Phellodendron amurense
extract inhibits cell cycle progression and lung tumorigenesis.
Mol Carcinog
50, no. 1 (2011): 1–7.

Jia, F., et al. Identification of palmatine as an inhibitor of West Nile virus.
Arch Virol
155, no. 8 (2010): 1325–29.

Kai-sum, M., et al. Coptis accumulation of active ingredients. Free Papers Download Center, May 17, 2008.
http://eng.hi138.com/?i135909
.

Kalman, D. S., et al. Effect of a proprietary
Magnolia
and
Phellodendron
extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial.
Nutr J
21, no. 7 (2008):11.

Karmakar, S. R., et al. Anti-carcinogenic potentials of a plant extract (
Hydrastis canadensis
): I. Evidence from in vivo studies in mice (
Mus musculus
).
Asian Pac J Cancer Prev
11, no. 2 (2010): 545–51.

Kheir, M. M., et al. Acute toxicity of berberine and its correlation with the blood concentration in mice.
Food Chem Toxicol
48, no. 4 (2010): 1105–10.

Khin-Maung-U, et al. Clinical trial of berberine in acute watery diarrhoea.
Br Med J (Clin Res Ed)
291, no. 6509 (1985): 1061–65.

Khin-Maung-U, et al. Clinical trial of high-dose berberine and tetracycline in cholera.
J Diarrhoeal Dis Res
5, no. 3 (1987): 184–87.

Kim, J. B., et al. The alkaloid berberine inhibits the growth of anoikis-resistant MCF-7 and MD-AMB-231 breast cancer cell lines by inducing cell cycle arrest.
Phytomedicine
17, no. 6 (2009): 436–40.

Kim, J. H., et al. Effect of
Phellodendron amurense
in protecting human osteoarthritic cartilage and chondrocytes.
J Ethnopharmacol
134, no. 2 (2011): 234–42. E-pub (preprint) December 21, 2010.

Kim, J. S., et al. Immunoquantitative analysis for berberine and its related compounds using monoclonal antibodies in herbal medicines.
Analyst
129, no. 1 (2004): 87–91.

Kulkami, S. K., et al. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders.
Phytother Res
24, no. 3 (2010): 317–24.

Kumar, A. P., et al. Akt/camp-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by nexrutine, a
Phellodendron amurense
bark extract.
Clin Cancer Res
13, no. 9 (2007): 2784–94.

Kumar, A. P., et al. Natural products: potential for developing
Phellodendron amurense
bark extract for prostate cancer management.
Mini Rev Med Chem
10, no. 5 (2010): 388–97.

Lau, C. W., et al. Cardiovascular actions of berberine.
Cardiovasc Drug Rev
19, no. 3 (2001): 234–44.

Lauk, L., et al. Activity of
Berberis aetnensis
root extracts on
Candida
strains.
Fitoterapia
78, no. 2 (2007): 159–61.

Lee, J. H., et al. Isolation and characterization of a novel glutathione S-transferase-activating peptide from the oriental medicinal plant
Phellodendron amurense
.
Peptides
27, no. 9 (2006): 2069–74.

Lesnau, A., et al. Antiviral activity of berberine salts.
Pharmazie
45, no. 8 (1990): 638–39.

Leu, C. H., et al. Constituents from the leaves of
Phellodendron amurense
and their antioxidant activity.
Chem Pharm Bull
(Tokyo), 54, no. 9 (2006): 1308–11.

Li, A., et al. Evaluation of antimicrobial activity of certain Chinese plants used in folkloric medicine.
World J Microbio Biotech
24, no. 4 (2008): 569–72.

Li, A.-R., et al. Antimicrobial activity of four species of Berberidaceae.
Fitoterapia
78, no. 5 (2007): 379–81.

Li, H. L., et al. Alkaloids from
Corydalis saxicola
and their anti-hepatitis B virus activity.
Chem Biodivers
5, no. 5 (2008): 777–83.

Li, H. L., et al. Simultaneous determination of four active alkaloids from a traditional Chinese medicine
Corydalis saxicola
Bunting. (yanhuanglian) in plasma and urine samples by LC-MS-MS.
J Chromatogr B Analyst Technol Biomed Life Sci
831, no. 1–2 (2006): 140–46.

Li, Y., et al. Effect of additives on absorption of
Coptis chinensis
total alkaloids and pharmacokinetics in mice.
Zhongguo Zhong Yao Za Zhi
34, no. 3 (2009): 344–48.

Liepin, V. K., et al. Seasons, regions of procurement of Amur corktree bast (
Phellodendron amurense
Rupr.) and localization of berberine in it.
Farmatsiia
17, no. 6 (1968): 65–69.

Lin, C. C., et al. Effects of oral administration of berberine on distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats.
In Vivo
21, no. 2 (2007): 321–28.

Lin, J. P., et al. Berberine induced down-regulation of matrix metalloproteinase-1, -2 and -9 in human gastric cancer cells (SNU-5) in vitro.
In Vivo
22, no. 2 (2008): 223–30.

Liu, L., et al. Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study.
Naunyn Schmiedebergs Arch Pharmacol
381, no. 4 (2010): 371–81.

Liu, Y., et al. Simultaneous determination of seven alkaloids in
Phellodendron chinense
Schneid by high-performance liquid chromatography.
J AOAC Int
93, no. 5 (2010): 1416–21.

Liu, Y. M., et al. A comparative study on commercial samples of phellodendri cortex.
Planta Med
59, no. 6 (1993): 557–61.

Lu, S. S., et al. Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats.
J Endocrinol
200, no. 2 (2009): 159–65.

Lu, T., et al. Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation huang-lian-jie-du decoction and the pharmacokinetic application of the method.
J Pharm Biomed Anal
40, no. 5 (2006): 1218–24.

Lu, X. Y., et al. Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine.
AAPS Pharm Sci Tech
11, no. 1 (2010): 372–82.

Ma, B. L., et al. Identification of the toxic constituents in rhizoma coptidis.
J Ethnopharmacol
128, no. 2 (2010): 357–64.

Ma, L., et al. Absorption of coptisine chloride and berberrubine across human intestinal epithelial by using human Caco-2 cell monolayers.
Zhongguo Zhong Yao Za Zhi
32, no. 23 (2007): 2523–27.

Maeng, H. J., et al. P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers.
J Pharm Sci
91, no. 12 (2002): 2614–21.

Mahady, G. B., et al. In vitro susceptibility of
Helicobacter pylori
to isoquinoline alkaloids from
Sanguinaria canadensis
and
Hydrastis canadensis
.
Phytother Res
17, no. 3 (2003): 217–21.

Min, Y. D., et al. Isolation of limonoids and alkaloids from
Phellodendron amurense
and their multidrug resistance (MDR) reversal activity.
Arch Pharm Res
30, no. 1 (2007): 58–63.

Miyake, M., et al. Limonoids in
Phellodendron amurense
(Kihada).
Yakugaku Zasshi
112, no. 5 (1992): 343–47.

Mori, H., et al. Principle of the bark of
Phellodendron amurense
to suppress the cellular immune response.
Planta Med
60, no. 5 (1994): 445–49.

Mori, H., et al. Principle of the bark of
Phellodendron amurense
to suppress the cellular immune response: effect of phellodendrine on cellular and humoral immune responses.
Planta Med
61, no. 1 (1995): 45–49.

Morisawa, TunyaLee.
Phellodendron amurense
. BugwoodWiki, updated March 23, 2009.
http://wiki.bugwood.org/Phellodendron_amurense
.

Musumeci, R., et al.
Berberis aetnensis
C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin.
Int J Antimicrob Agents
22, no. 1 (2003): 48–53.

Oben, J., et al.
Phellodendron
and
Citrus
extracts benefit cardiovascular health in osteoarthritis patients: a double-blind, placebo-controlled pilot study.
Nutr J
20, no. 7 (2008): 16.

Oben, J., et al.
Phellodendron
and
Citrus
extracts benefit joint health in osteoarthritis patients: a pilot, double-blind, placebo-controlled study.
Nutr J
14, no. 8 (2009): 38.

Pan, G. Y., et al. The involvement of P-glycoprotein in berberine absorption.
Pharmacol Toxicol
91, no. 4 (2002): 193–97.

Park, E. K. Antiinflammatory effects of a combined herbal preparation (RAH13) of
Phellodendron amurense
and
Coptis chinensis
in animal models of inflammation.
Phytother Res
21, no. 8 (2007): 746–50.

Park, K. S., et al. Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in
Candida albicans
.
J Antimicrob Chemother
43, no. 5 (1999): 667–74.

Park, K. S., et al. HWY-289, a novel semi-synthetic protoberberine derivative with multiple target sites in
Candida albicans
.
J Antimicrob Chemother
47, no. 5 (2001): 513–19.

Ping, Yi., et al. Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKK.
World J Gastroenterology
14, no. 6 (2008): 876–83.

Pitta-Alvarez, S. I., et al. In vitro shoot culture and antimicrobial activity of
Berberis buxifolia
Lam.
In Vitro Cell Dev Biol Plant
44, no. 6 (2008): 502–7.

Premkumar, J., et al. Activity and interactions of antibiotic and phytochemical combinations against
Pseudomonas aeruginosa
in vitro.
Int J Biol Sci
6, no. 6 (2010): 556–68.

Quan, H., et al. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of
Candida albicans
resistant to fluconazole.
Antimicrob Agents Chemother
50, no. 3 (2006): 1096–99.

Qui, W., et al. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp.
Phytother Res
23, no. 11 (2009): 1553–58.

Rabbani, G. H., et al. Mechanism and treatment of diarrhoea due to
Vibrio cholerae
and
Escherichia coli
: roles of drugs and prostaglandins.
Dan Med Bull
43, no. 2 (1996): 173–85.

Rabbani, G. H., et al. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic
Escherichia coli
and
Vibrio cholerae
.
J Infect Dis
155, no. 5 (1987): 979–84.

Rajaian, H., et al.
Berberis vulgaris
as growth promoter in broiler chickens.
Int J Poultry Sci
5, no. 4 (2006): 395–97.

Read, R. A., and J. Zasada.
Phellodendron amurense
Rupr.: Amur corktree. In
Woody Plant Seed Manual
, by the U.S. Department of Agriculture Forest Service (USDAFS Agriculture Handbook 727), 783–85. Washington DC: U.S. Government Printing Office, 2008.
http://www.nsl.fs.fed.us/O&P%20genera.pdf
.

Rohrer, U., et al. Antimicrobial activity of
Mahonia aquifolium
and two of its alkaloids against oral bacteria.
Schweiz Monatsschr Zahnmed
117 (2007): 1126–31.

Ropivia, J., et al. Isoquinolines from the roots of
Thalictrum flavum
L. and their evaluation as antiparasitic compounds.
Molecules
15 (2010): 6476–84.

Sack, R. B., et al. Berberine inhibits intestinal secretory response of
Vibrio cholerae
and
Escherichia coli
enterotoxins.
Infect Immun
35, no. 2 (1982): 471–75.

Sahelian, Ray.
Phellodendron.
Newsletter.
http://raysahelian.com/phellodendron.html
(accessed January 25, 2011).

Sato, I., et al. The study of dentifrice containing
Phellodendron amurense
extract on periodontal disease (II). The clinical effects of dentifrice containing
Phellodendron amurense
extract and anti-inflammatory agents.
Nihon Shishubyo Gakkai Kaishi
30, no. 3 (1988): 887–900.

Scazzocchio, F. et al. Antibacterial activity of
Hydrastis canadensis
extract and its major isolated alkaloids.
Planta Med
67, no. 6 (2001): 561–64.